Anheuser-Busch Inbev
BUD
76.68
+2.06
+2.76%
Anheuser-Busch Inbev
US · BUD
#136 by market cap
Listed 1970
76.68
+2.06
+2.76%
Live - 5344 symbols - heartbeat 192s ago
· 2026-10-08 10:10
Pre-market
76.03
+1.89%
After-hours
74.62
0.00%
Overnight
74.64
+0.03%
- Market cap
- 151.22B
- P/E (TTM)i
- 16.53
- P/Bi
- 1.62
- EPSi
- 3.39
- Div yieldi
- 1.76%
- 52W posi
- 65%
Reader sentiment
Are you bullish or bearish on BUD?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.52, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -0.75% YoY
Margins
- Gross margin
- 55.93%
- Operating margin
- 26.38%
- Net margin
- 11.53%
Key ratios & quality
- Enterprise valuei
- 210.64B
- PEG ratioi
- 3.57
- Altman Z-Scorei
- 1.52
PEG uses trailing P/E against the 3-year net income growth rate (4.63%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 53.04B | 52.33B | 46.88B | 54.30B | 57.79B | 59.38B | 59.77B | 59.32B |
| Gross profit | 33.11B | 31.97B | 27.25B | 31.21B | 31.48B | 31.98B | 33.02B | 33.18B |
| Selling & admin expenses | 16.81B | 16.42B | 15.37B | 17.58B | 17.56B | 18.17B | 18.34B | 18.13B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 16.54B | 15.77B | 12.61B | 14.21B | 14.47B | 14.41B | 15.27B | 15.65B |
| Pretax profit | 7.74B | 12.78B | 2.08B | 8.46B | 9.52B | 9.12B | 10.57B | 11.33B |
| Tax | 2.59B | 2.79B | 1.93B | 2.35B | 1.93B | 2.23B | 3.15B | 2.85B |
| Net profit | 5.69B | 10.41B | 2.20B | 6.11B | 7.60B | 6.89B | 7.42B | 8.48B |
| Basic EPS | 2 | 5 | 1 | 2 | 3 | 3 | 3 | 3 |
| Diluted EPS | 2.17 | 4.53 | 0.69 | 2.28 | 2.91 | 2.60 | 2.86 | 3.39 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 13.63B | 15.00B | 15.13B | 15.56B | 15.27B | 16.66B |
| Gross profit | 7.58B | 8.45B | 8.54B | 8.61B | 8.65B | 9.58B |
| Selling & admin expenses | 4.19B | 4.62B | 4.54B | 4.79B | 4.74B | 5.18B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 3.59B | 4.01B | 4.21B | 4.05B | 4.07B | 4.60B |
| Pretax profit | 3.21B | 2.77B | 2.26B | 3.10B | 3.76B | 5.00B |
| Tax | 664.00M | 741.00M | 726.00M | 720.00M | 786.00M | 918.00M |
| Net profit | 2.54B | 2.03B | 1.53B | 2.38B | 2.98B | 4.09B |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 2 |
| Diluted EPS | 1.08 | 0.84 | 0.53 | 0.99 | 1.30 | 1.90 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 18.28B | 28.81B | 26.52B | 23.95B | 23.19B | 23.37B | 23.00B | 24.77B |
| Cash & ST investments | 7.16B | 7.25B | 15.56B | 12.39B | 10.00B | 10.40B | 11.30B | 11.84B |
| Inventory | 4.11B | 4.32B | 4.39B | 5.28B | 6.53B | 5.46B | 4.94B | 4.97B |
| Total assets | 233.87B | 236.65B | 226.41B | 217.63B | 212.94B | 219.34B | 206.64B | 218.81B |
| Total current liabilities | 34.83B | 34.84B | 32.35B | 34.18B | 34.38B | 37.16B | 33.07B | 34.48B |
| Short-term debt | 4.70B | 5.48B | 3.09B | 1.46B | 1.11B | 4.00B | 1.45B | 898.00M |
| Long-term debt | 105.42B | 95.87B | 93.64B | 85.54B | 76.92B | 72.04B | 68.97B | 70.35B |
| Total liabilities | 161,979,000,000.00 | 152,095,000,000.00 | 148,059,000,000.00 | 138,287,000,000.00 | 128,665,000,000.00 | 126,664,000,000.00 | 117,937,000,000.00 | 121,072,000,000.00 |
| Total equity | 71.89B | 84.55B | 78.35B | 79.34B | 84.28B | 92.68B | 88.70B | 97.74B |
| Retained earnings | 26.07B | 31.48B | 30.87B | 33.88B | 38.82B | 42.22B | 46.58B | 50.13B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | -- | 21.22B | -- | 24.77B | -- | 22.24B |
| Cash & ST investments | -- | 7.27B | -- | 11.84B | -- | 7.91B |
| Inventory | -- | 5.48B | -- | 4.97B | -- | 5.53B |
| Total assets | -- | 211.11B | -- | 218.81B | -- | 218.39B |
| Total current liabilities | -- | 33.01B | -- | 34.48B | -- | 33.48B |
| Short-term debt | -- | 3.60B | -- | 898.00M | -- | 3.41B |
| Long-term debt | -- | 70.24B | -- | 70.35B | -- | 67.30B |
| Total liabilities | -- | 119,693,000,000.00 | -- | 121,072,000,000.00 | -- | 117,200,000,000.00 |
| Total equity | -- | 91.41B | -- | 97.74B | -- | 101.19B |
| Retained earnings | -- | 47.64B | -- | 50.13B | -- | 51.69B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 15.06B | 14.04B | 10.89B | 14.80B | 13.30B | 13.27B | 15.06B | 14.88B |
| Depreciation & amortization | 4.62B | 4.66B | 4.83B | 5.05B | 5.08B | 5.41B | 5.54B | 5.65B |
| Free cash flow | 10.06B | 8.86B | 7.11B | 9.16B | 8.14B | 8.63B | 11.19B | 11.23B |
| Dividends paid | -7.76B | -5.02B | -1.80B | -2.36B | -2.44B | -3.01B | -2.67B | -4.54B |
| Stock buybacks / issuance | -- | -- | -- | 0 | 0 | -362.00M | -937.00M | -2.30B |
| Ending cash balance | 6.96B | 7.17B | 15.25B | 12.04B | 9.89B | 10.31B | 11.17B | 11.62B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | -- | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | -- | -- | -- | -- | -- | -- |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | -- | -- | -- | -- | -- | -- |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 6.37 | 13.08 | 1.95 | 6.83 | 8.40 | 6.88 | 7.31 | 8.26 |
| ROA %i | 1.83 | 3.91 | 0.61 | 2.10 | 2.77 | 2.47 | 2.75 | 3.21 |
| ROIC %i | 3.96 | 7.17 | 2.49 | 4.66 | 5.89 | 5.22 | 5.30 | 5.94 |
| 5-year avg ROE %i | 11.20 | 10.14 | 6.94 | 7.87 | 7.33 | 7.43 | 6.28 | 7.54 |
| EBIT margin %i | 24.06 | 33.77 | 14.14 | 23.45 | 24.06 | 23.00 | 24.68 | 25.61 |
| FCF / sales %i | 17.53 | 15.71 | 15.17 | 16.87 | 14.08 | 14.53 | 18.73 | 18.93 |
| Current ratioi | 0.52 | 0.83 | 0.82 | 0.70 | 0.67 | 0.63 | 0.70 | 0.72 |
| Quick ratioi | 0.39 | 0.39 | 0.64 | 0.51 | 0.46 | 0.45 | 0.51 | 0.53 |
| Debt / assetsi | 47.76 | 43.54 | 43.53 | 40.82 | 37.56 | 35.64 | 34.93 | 33.37 |
| LT debt / equityi | 165.93 | 128.85 | 140.36 | 127.23 | 107.47 | 90.61 | 90.39 | 82.63 |
| Interest coveragei | 2.85 | 3.61 | 1.46 | 2.98 | 3.17 | 3.01 | 3.53 | 3.93 |
| Revenue CAGR (3Y) %i | 7.19 | 4.76 | -5.10 | 0.79 | 3.36 | 8.20 | 3.25 | 0.88 |
| Net income CAGR (3Y) %i | -19.16 | 94.78 | -43.98 | 2.24 | -13.34 | 56.07 | 7.83 | 4.63 |
| FCF CAGR (3Y) %i | 2.39 | 19.98 | -11.45 | -3.08 | -2.80 | 6.66 | 6.91 | 11.32 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | 8.94 | -- | 8.26 | -- | 10.71 |
| ROA %i | -- | 3.37 | -- | 3.21 | -- | 4.34 |
| ROIC %i | -- | 6.10 | -- | 5.94 | -- | 7.34 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 24.97 | 26.83 | 25.25 | 25.61 | 25.90 | 28.75 |
| FCF / sales %i | -- | 19.92 | -- | 18.93 | -- | 21.98 |
| Current ratioi | -- | 0.64 | -- | 0.72 | -- | 0.66 |
| Quick ratioi | -- | 0.43 | -- | 0.53 | -- | 0.45 |
| Debt / assetsi | -- | 35.80 | -- | 33.37 | -- | 33.11 |
| LT debt / equityi | -- | 89.23 | -- | 82.63 | -- | 73.70 |
| Interest coveragei | 3.82 | 3.98 | 3.67 | 3.93 | 4.04 | 4.64 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Middle Americas is the largest reported line at 29.51% of revenue, across 6 reported segments.
- No single line clears half of revenue; South America is next at 22.53%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Middle Americas29.51%
South America22.53%
North America22.17%
EMEA14.89%
Asia Pacific9.65%
Global export and holding companies1.24%
Quote time 2026-10-08 10:10:14 · For reference only, not investment advice and not tailored to your situation.